Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Endocrine Connections
|
August 8, 2024
Associations between circulating levels of FABP4 and TNF receptors are more evident in patients with type 2 diabetes mellitus than in patients with type 1 diabetes mellitus
Marenao Tanaka, Tomohito Gohda, Nozomu Kamei, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
March 16, 2025
High Level of Estimated Small Dense Low-Density Lipoprotein Cholesterol as an Independent Risk Factor for the Development of Ischemic Heart Disease Regardless of Low-Density Lipoprotein Cholesterol Level - A 10-Year Cohort Study
Keisuke Endo, Marenao Tanaka, Tatsuya Sato, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
July 24, 2024
High Intraocular Pressure Is Independently Associated With New-Onset Systemic Hypertension Over a 10-Year Period
Araya Umetsu, Marenao Tanaka, Tatsuya Sato, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension
|
August 2, 2023
An increase in calculated small dense low-density lipoprotein cholesterol predicts new onset of hypertension in a Japanese cohort
Marenao Tanaka, Tatsuya Sato, Keisuke Endo, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension
|
October 16, 2023
A high level of thyroid-stimulating hormone is a risk factor for the development of chronic kidney disease in men: a 10-year cohort study
Keisuke Endo, Marenao Tanaka, Tatsuya Sato, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)
|
January 8, 2025
Machine learning-based analyses of contributing factors for the development of hypertension: a comparative study
Marenao Tanaka, Yukinori Akiyama, Kazuma Mori, et al.
Journal of Atherosclerosis and Thrombosis
|
August 30, 2023
Calculated Small Dense Low-Density Lipoprotein Cholesterol Level is A Predominant Predictor for New Onset of Ischemic Heart Disease
Masafumi Inyaku, Marenao Tanaka, Tatsuya Sato, et al.
Frontiers in Endocrinology
|
August 1, 2025
Treatment with pemafibrate ameliorates fatty liver index and atherogenic lipid profiles in Japanese patients with type 2 diabetes mellitus
Toru Suzuki, Tatsuya Sato, Marenao Tanaka, et al.
Journal of Atherosclerosis and Thrombosis
|
January 3, 2024
Validation of Estimated Small Dense Low-Density Lipoprotein Cholesterol Concentration in a Japanese General Population
Keisuke Endo, Ryo Kobayashi, Makito Tanaka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
August 7, 2024
Metabolic dysfunction-associated steatotic liver disease (SLD) and alcohol-associated liver disease, but not SLD without metabolic dysfunction, are independently associated with new onset of chronic kidney disease during a 10-year follow-up period
Kazuma Mori, Marenao Tanaka, Tatsuya Sato, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Endocrine Connections
|
August 8, 2024
Associations between circulating levels of FABP4 and TNF receptors are more evident in patients with type 2 diabetes mellitus than in patients with type 1 diabetes mellitus
Marenao Tanaka, Tomohito Gohda, Nozomu Kamei, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
March 16, 2025
High Level of Estimated Small Dense Low-Density Lipoprotein Cholesterol as an Independent Risk Factor for the Development of Ischemic Heart Disease Regardless of Low-Density Lipoprotein Cholesterol Level - A 10-Year Cohort Study
Keisuke Endo, Marenao Tanaka, Tatsuya Sato, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
July 24, 2024
High Intraocular Pressure Is Independently Associated With New-Onset Systemic Hypertension Over a 10-Year Period
Araya Umetsu, Marenao Tanaka, Tatsuya Sato, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension
|
August 2, 2023
An increase in calculated small dense low-density lipoprotein cholesterol predicts new onset of hypertension in a Japanese cohort
Marenao Tanaka, Tatsuya Sato, Keisuke Endo, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension
|
October 16, 2023
A high level of thyroid-stimulating hormone is a risk factor for the development of chronic kidney disease in men: a 10-year cohort study
Keisuke Endo, Marenao Tanaka, Tatsuya Sato, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)
|
January 8, 2025
Machine learning-based analyses of contributing factors for the development of hypertension: a comparative study
Marenao Tanaka, Yukinori Akiyama, Kazuma Mori, et al.
Journal of Atherosclerosis and Thrombosis
|
August 30, 2023
Calculated Small Dense Low-Density Lipoprotein Cholesterol Level is A Predominant Predictor for New Onset of Ischemic Heart Disease
Masafumi Inyaku, Marenao Tanaka, Tatsuya Sato, et al.
Frontiers in Endocrinology
|
August 1, 2025
Treatment with pemafibrate ameliorates fatty liver index and atherogenic lipid profiles in Japanese patients with type 2 diabetes mellitus
Toru Suzuki, Tatsuya Sato, Marenao Tanaka, et al.
Journal of Atherosclerosis and Thrombosis
|
January 3, 2024
Validation of Estimated Small Dense Low-Density Lipoprotein Cholesterol Concentration in a Japanese General Population
Keisuke Endo, Ryo Kobayashi, Makito Tanaka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
August 7, 2024
Metabolic dysfunction-associated steatotic liver disease (SLD) and alcohol-associated liver disease, but not SLD without metabolic dysfunction, are independently associated with new onset of chronic kidney disease during a 10-year follow-up period
Kazuma Mori, Marenao Tanaka, Tatsuya Sato, et al.
Page
of 3